Dow Jones Top Company Headlines at 5 PM ET: Tesla Sales Jumped in Second Quarter | Google ...

Dow Jones
12 hours ago

Tesla Sales Jumped in Second Quarter

The electric automaker sells just three new-car models now, with CEO Elon Musk putting the focus on autonomous vehicles and robotics.

----

Google Loses Fight Against EU's $4.7 Billion Android Fine

The penalty is the largest the EU has handed the company in its efforts to curb Google's online dominance.

----

Blue Owl Investors Ask to Withdraw $4.7 Billion From Flagship Funds

Redemption requests declined from the previous quarter but remained elevated.

----

Tesla Driver Charged With Manslaughter After Crashing Into Texas Home, Killing Woman

Investigators say the driver acted to override the car's automated driving assistance system.

----

SAP Seeks to Rein In Costs to Focus on AI Investments

SAP said it would exercise greater discipline when it comes to hiring and travel expenses as it seeks to redeploy workers in roles where they can make better use of AI.

----

German Drone Maker Quantum Systems Raises Funding at $8 Billion Valuation

Quantum Systems said it had raised $1.2 billion at a valuation of roughly $8 billion, bringing in fresh capital to expand drone production and invest in software for autonomous systems powered by artificial intelligence.

----

Starlink Dominates Internet From Space. Can It Disrupt AT&T and Verizon on the Ground?

SpaceX wants its satellite network to eventually serve cellphones in dense urban areas, but capacity and infrastructure hurdles remain.

----

National Beverage Stock Jumps After LaCroix Owner Declares Special Dividend

National Beverage, the maker of LaCroix sparkling water, announced its 13th special dividend in 22 years, sending shares sharply higher despite mixed annual results.

----

Why Medicare Isn't a Game Changer for Weight-Loss Drugmakers

Medicare is now covering weight-loss drugs for some seniors, in a win for patients. For Wall Street, the math is trickier.

----

Norway's Yara to Buy Texas Ammonia Plant For $1.3 Billion

The addition of U.S. production capacity supports the fertilizer producer's strategy of diversifying energy exposure, capturing economies of scale, and lowering fixed costs.

----

Chanel Snaps Up Storied French Shirtmaker Charvet

It is a rare acquisition for the fashion house as it looks to further widen its offer beyond its famed luxury handbags.

----

Consumers Shun Mid-Sized Packs Amid Price Squeeze, Nestle Says

The company is working to keep prices in check, as U.S. consumers fixate on affordability and buyers shift toward bulk or budget pack sizes, passing over middle formats.

----

Brightline Buys Time as Bankruptcy Loan Talks Continue

After extending its interest payment deadline and securing a small financing, Brightline secures two more weeks to negotiate with lenders.

----

KKR and Energy Capital Partners Look to Bet on DCC's Industry Pivot

The private-equity firms aim to gain from the multi-industry conglomerate's recent pivot to focus on its energy businesses, analysts say

----

Roche Lung-Cancer Drug Candidate Beats Existing Therapies in Late-Stage Trial

Experimental drug, divarasib, showed meaningful improvements in both patients' overall survival and the time they survived without the disease worsening.

 

(END) Dow Jones Newswires

July 02, 2026 17:00 ET (21:00 GMT)

Copyright (c) 2026 Dow Jones & Company, Inc.

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10